), a finding which strengthens the above hypothesis. A mouse whose cell constitutively express PCK has been reported to be super athlete since it ran over 6 km when control mouse only ran 0.2 km 19 . Therefore, a verification of the high energy-charged single cell as a factory works better for human purposed biomolecule synthesis is required.
Introduction
Adenosine triphosphate (ATP) is the universal energy currency of the cell, transferring the chemical energy from metabolism to various biological activities in all life forms on earth 1 . ATP is produced during the processes of photosynthesis, fermentation, and respiration, and it is consumed by many processes, such as biosynthesis, motility, cell signaling, and cell division. ATP consists of adenosine and three phosphates and chemical energy is released by cleavage of a phosphate to produce adenosine diphosphate (ADP) + phosphate. Since ATP is an unstable molecule, it is hydrolyzed spontaneously and therefore is continuously recycled in living organisms; i.e., a human turns over the equivalent of its body weight in ATP every day 2 . It is well known that the intracellular ATP concentration is one of the most important factors for cellular physiology, since it regulates many cellular events, such as growth 3 , ribosomal RNA synthesis 4 , and cellular metabolic pathways 5 .
Biomaterial synthesis is an age-old knowledge involved in the manufacturing of bread, beer, wine, and cheese. The recent concept of biomaterial synthesis, however, is the use of live cells as factories for manufacturing highly valued biomaterials, such as proteins, amino acids, alcohols, organic acids, solvents, as well as bioplastics used in molecular biology and bioinformatics 6 . Many living cell factory models have been studied for the (Fig. 1) , a finding which strengthens the above hypothesis. A mouse whose cell constitutively express PCK has been reported to be super athlete since it ran over 6 km when control mouse only ran 0.2 km 19 . Therefore, a verification of the high energy-charged single cell as a factory works better for human purposed biomolecule synthesis is required.
In this paper, we artificially expressed heterologous enhanced green fluorescence protein (eGFP) in E. coli BL21(DE3) that maintain a high intracellular ATP to determine whether this strain is eligible for use as a powerful, protein-synthesizing cell factory. The potential uses of such a high energy-charged cell factory are also discussed.
Results
To estimate heterologous protein expression in a high energy-charged cell, enhanced green fluorescence protein (eGFP) was expressed under control of the T7 promoter in an E. coli BL21(DE3) host ( 78.4 nmol/mg-protein). The total protein contents of BL21(DE3)/pEGFP was 0.60 mg/mL and that of the BL21(DE3)/pEcPCK/pEGFP was 0.55 mg/mL. The amount of eGFP expression in BL21(DE3) overexpressing PCK was 957.8 RF(relative fluorescence)/mL, which is more than 2-times greater than that observed for the control 6 strain (443.5 RF/mL) (Fig 2) . The specific amount of eGFP produced by the unit cell of high energy-charged E. coli (1741.5 RF/mg-protein) was 2.4-times greater than that produced by the control (739 RF/mg-protein).
Discussion
The high energy-charged E. coli was beneficial for the expression of foreign protein (Table 1 , Fig. 2 , Suppl. 1). One explanation for this result could be that these high energy-charged cells up-regulate the genes for biosynthesis of amino acids 18 , thus increasing amino acid biosynthesis turnover. An increase in the rate of production of ribosomes by cells at a higher energy state has been reported 4 and it is another potential explanation for the observed enhancement of foreign protein synthesis (Suppl. 2). The decreased growth rate observed for the high energy-charged cells were found in the LBglucose and the minimal glucose medium (data not shown) and that is reasonable considering that a high energy charge has been reported to limit the cellular growth by restriction of the glycolytic flux 20 , under such conditions, the carbon would be redirected to foreign protein synthesis rather than to growth. E. coli BL21(DE3) has been widely used for production of recombinant proteins and the whole genome sequence of BL21(DE3) was reported lacks of genes for the motility (21 fli genes) as well as Lon protease 21 . The amount eGFP from the high energy-charged BL21(DE3) host (957.8 RF/mL) was found to be about 57% more than that from the high energy-charged The use of high energy-charged cells could be beneficial to other cell factory applications in addition to foreign protein synthesis. For instance, high energy-charged cells might be able to enhance the production of a metabolite such as succinic acid, a widely used specialty chemical 22 . When a recombinant cell directs its metabolism toward production of a target metabolite, it tends to restrict its metabolic pathways by way of feedback control. If the target metabolite remains inside the cell factory, and accumulates to a high concentration, it would eventually inhibit its own synthesis.
Active transport the of target metabolite using the energy of the high-powered cell factory could prevent feedback control from occurring, thereby enabling synthesis via the desired pathways to continue unabated 23 . In addition to the export of products, the high-level intracellular energy could be useful for the import of raw materials into the cell factory; one could expect to increase the rate of biomaterial synthesis once the regulation of the carbon influx by the high energy-charged cells is understood. Secretion and surface display of proteins might also be enhanced by the availability of high-level intracellular energy 24 .
It is not clear whether high energy-charged cells other than E. coli would be better suited as cell factories for foreign protein synthesis. Studies on the engineering and use of other types of cells (i.e., yeast, mammalian cell) as high energy-charged cell factories are therefore needed.
Methods

Strain and plasmids
All strains, plasmids, and oligonucleotides are summarized in Table 2 
Media and culture
Luria-Bertani medium was used for routine DNA manipulations. The LB-glucose medium contained glucose (9 g/L), NaHCO 3 (10 g/L), yeast extract (5 g/L), tryptone (10 g/L), NaCl (10 g/L), and antibiotics (ampicillin and kanamycin, 50 ȝg/mL) 25 . Single colony was inoculated into a 15-mL tube containing 4 mL medium and maintained at 37ºC and 250 rpm for 12h. Four hundred microliter of culture was transferred into a 250-mL Erlenmeyer flask containing 50 mL medium and maintained at 37ºC and 250 rpm. When the optical density (O.D.) of culture reached 0.6, isopropyl-E-Dthiogalactopyranoside (IPTG, 1 mM) was supplemented to allow eGFP expression.
After 6 h after IPTG induction, culture was withdrawn for the analysis.
Analysis
Biomass was estimated by measuring O.D. at 600 nm. Intracellular [ATP] and PCK enzyme activity were determined as described previously 26 . The protein concentration of the enzyme solution was determined using a protein assay kit (Bio-Rad, La Jolla, CA, USA) with bovine serum albumin as a standard after the sonic disruption of the sample for 5 min at 140 W on ice using a UP200S ultrasonic processor (Hielscher Ultrasonics Co., Teltow, Germany). To estimate the amount of eGFP expression, a 700 PL-sample was subjected to fluorescence spectroscopy (RF-5301PC, Shimadzu, Kyoto, Japan) with excitation at 395 nm and emission at 509 nm. Cells were observed using phase contrast and fluorescence microscopy (AX-70, Olympus Co, Tokyo, Japan).
List of Table   Table 1 . Effect of intracellular ATP level on eGFP expression. All experiments were repeated at least 5 times. Samples were harvested at 6 h of IPTG induction. Cells were cultured in a 250-mL Erlenmeyer flask containing 5 mL medium at 250 rpm, and 37qC. b A culture sample was directly subjected to fluorescence spectrophotometry (excitation at 395 nm, emission at 509 nm) for estimation of eGFP expression. 
